Assessing Long-Term Maintenance Of Efficacy With Tralokinumab Monotherapy In Patients With Moderate-To-Severe Atopic Dermatitis: Combined Results From Two Phase Iii, Randomized, Double-Blind, Placebo-Controlled Trials (Ecztra 1 And 2)
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2021）
摘要
N/A
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要